This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NYSE, Primerica: New Targets, Estimates

Also see: Nokia, LinkedIn: Analysts' New Ratings


Air Products (APD - Get Report) numbers were raised at Morgan Stanley. Shares now seen reaching $115. Estimates also increased, given better end-market demand, Morgan Stanley said. Overweight rating.

Dow Chemical (DOW - Get Report) estimates were lowered through 2012 at UBS. Lower pricing could hurt near-term margins, UBS said. Buy rating and $46.50 price target.

WR Grace (GRA - Get Report) estimates were increased through 2012 at Jefferies. Company has multiple potential growth drivers, Jefferies said. Buy rating and $56 price target.

Nasdaq (NDAQ) estimates, target were reduced at Barclays. Shares now seen reaching $32. Estimates also cut, as trading volume has declined, Barclays said. Overweight rating.

NYSE Euronext (NYX) numbers were cut at Barclays. Shares now seen reaching $41. Estimates also lowered, given lower trading volume in Europe, Barclays said. Overweight rating.

Primerica (PRI - Get Report) estimates, target were reduced at UBS. Shares of PRI now seen reaching $22. Estimates also cut, given weaker equity markets and slower economic growth, UBS said. Neutral rating.

RadioShack (RSH) estimates, target were lowered through 2012 at Barclays Capital. The company continues to face cost headwinds, Barclays said. Underweight rating and new $12 price target.

Seattle Genetics (SGEN - Get Report) numbers were boosted at ThinkEquity. Shares are now seen reaching $26. Estimates also upped, given better expected pricing for Adcetris, according to ThinkEquity. Buy rating.

End of report.
This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
NYX $0.00 0.00%
APD $132.46 1.31%
DOW $46.60 0.80%
GRA $68.31 5.17%
PRI $41.17 -0.75%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs